Dr. Jianan Graybill, is a radiation oncologist and certified MD Anderson Cancer Network® physician.
There are only a few cancer centers in the country that offer high dose rate brachytherapy. Community Cancer Care is one of them.
Commonly called HDR brachytherapy, this cancer treatment is a form of temporary seed implant used to treat prostate cancer. It is the ultimate conformal therapy.
“HDR Brachytherapy has the ability to shape the radiation dose to fit the (prostate) tumor and avoid normal tissue,” said Graybill.
HDR brachytherapy can be used alone or in combination with other treatment modalities, such as external beam radiation. Guidelines from American Brachytherapy Society recommend that HDR brachytherapy be considered as a way to escalate the dose of radiation in men receiving radiation therapy as their primary therapy for prostate cancer.
HDR brachytherapy is particularly useful in men with intermediate or high-risk prostate cancer because it can provide highly conformal dose escalation to the target region. HDR eliminates the need to have surgery, prolonged hospitalization or protracted external beam treatments. It provides greater patient comfort during and after the procedure and requires minimal recovery time.
A recent quality of life and cost analysis study showed that HDR provides the most cost efficient treatment with the best quality of life outcome. When combined with external bream radiation, HDR and external bream provided increased disease free survival in intermediate and high-risk prostate cancer patient populations compared with external beam radiation.Cancer treatment at Community
For more information about Community Cancer Care services call 800.777.7775.